Literature DB >> 27640609

Positron Emission Tomography/Computed Tomography for Gynecologic Malignancies.

Jorge Daniel Oldan1, Parth S Patel2.   

Abstract

IMPORTANCE: Positron emission tomography/Computed tomography(PET/CT) is widely used for gynecologic cancers.
OBJECTIVE: To determine when PET/CT should be used for gynecologic cancers. EVIDENCE ACQUISITION: PubMed was reviewed for articles on PET/CT of all gynecologic cancers. National Comprehensive Cancer Network, Society of Gynecologic Oncology, and American College of Radiology guidelines were reviewed.
RESULTS: Whole-body PET/CT is useful for (1) initial staging of cervical and endometrial cancer, posttherapy assessment, radiation therapy planning, and posttreatment surveillance of cervical cancer, and (2) assessment of recurrence of cervical, endometrial, or ovarian cancer in the presence of symptoms. It is also useful for staging and recurrence of uterine sarcomas, and for staging of vulvar and vaginal cancer.
CONCLUSIONS: Positron emission tomography/Computed tomography is clinically valuable for a variety of gynecologic cancers. RELEVANCE: PET/CT plays an important role in detection of initial disease and recurrence of gynecologic malignancies.

Entities:  

Mesh:

Year:  2016        PMID: 27640609     DOI: 10.1097/OGX.0000000000000345

Source DB:  PubMed          Journal:  Obstet Gynecol Surv        ISSN: 0029-7828            Impact factor:   2.347


  2 in total

1.  Gliomatosis peritonei with 18F-fluorodeoxyglucose accumulation and contrast enhancement secondary to immature teratoma: A case report.

Authors:  Tsutomu Ohara; Koji Yamanoi; Yoshihide Inayama; Jumpei Ogura; Mie Sakai; Haruka Suzuki; Takahiro Hirayama; Koji Yasumoto; Ko Suginami
Journal:  Mol Clin Oncol       Date:  2018-05-02

2.  Leptomeningeal carcinomatosis and bilateral internal auditory canal metastases from ovarian carcinoma.

Authors:  Martin Krupa; Kathy Byun
Journal:  Radiol Case Rep       Date:  2017-04-05
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.